Current Ratio of Theravance Biopharma, Inc. from 30 Sep 2014 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Theravance Biopharma, Inc. quarterly Current Ratio in % history and change rate from 30 Sep 2014 to 30 Sep 2025.
  • Theravance Biopharma, Inc. Current Ratio for the quarter ending 30 Sep 2025 was 663%, a 25% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Change (%)

Theravance Biopharma, Inc. Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q3 2025 663% +131% +25% 30 Sep 2025
Q2 2025 561% -8.1% -1.4% 30 Jun 2025
Q1 2025 498% -137% -22% 31 Mar 2025
Q4 2024 520% -222% -30% 31 Dec 2024
Q3 2024 532% -392% -42% 30 Sep 2024
Q2 2024 569% -26% -4.4% 30 Jun 2024
Q1 2024 635% +77% +14% 31 Mar 2024
Q4 2023 742% +248% +50% 31 Dec 2023
Q3 2023 924% +520% +129% 30 Sep 2023
Q2 2023 595% +145% +32% 30 Jun 2023
Q1 2023 558% +98% +21% 31 Mar 2023
Q4 2022 494% +73% +17% 31 Dec 2022
Q3 2022 404% +20% +5.3% 30 Sep 2022
Q2 2022 450% +64% +17% 30 Jun 2022
Q1 2022 460% +71% +18% 31 Mar 2022
Q4 2021 422% -12% -2.8% 31 Dec 2021
Q3 2021 384% -50% -11% 30 Sep 2021
Q2 2021 385% -21% -5.1% 30 Jun 2021
Q1 2021 389% +2.7% +0.69% 31 Mar 2021
Q4 2020 434% +77% +21% 31 Dec 2020
Q3 2020 433% +20% +4.8% 30 Sep 2020
Q2 2020 406% -8.4% -2% 30 Jun 2020
Q1 2020 386% -36% -8.5% 31 Mar 2020
Q4 2019 357% -68% -16% 31 Dec 2019
Q3 2019 413% -12% -2.8% 30 Sep 2019
Q2 2019 415% -95% -19% 30 Jun 2019
Q1 2019 422% -155% -27% 31 Mar 2019
Q4 2018 426% -288% -40% 31 Dec 2018
Q3 2018 425% -408% -49% 30 Sep 2018
Q2 2018 509% -292% -36% 30 Jun 2018
Q1 2018 577% -234% -29% 31 Mar 2018
Q4 2017 714% -9.9% -1.4% 31 Dec 2017
Q3 2017 834% +267% +47% 30 Sep 2017
Q2 2017 801% +196% +32% 30 Jun 2017
Q1 2017 811% +151% +23% 31 Mar 2017
Q4 2016 724% -53% -6.8% 31 Dec 2016
Q3 2016 567% -294% -34% 30 Sep 2016
Q2 2016 606% -251% -29% 30 Jun 2016
Q1 2016 660% -190% -22% 31 Mar 2016
Q4 2015 777% +147% +23% 31 Dec 2015
Q3 2015 860% +385% +81% 30 Sep 2015
Q2 2015 857% 30 Jun 2015
Q1 2015 849% 31 Mar 2015
Q4 2014 630% 31 Dec 2014
Q3 2014 475% 30 Sep 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.